Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
STIM · against 195 other Healthcare companies of similar size
Ranked #127 of 196 · scores higher than 10% of peers
Bars: peers in each 10-point band of the valuation score70 peers with a valuation score of 0–9, including STIM · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | STIM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 178 reported | -19.0% | -5.3% | 37% | 30% | |
| EBITDA yieldHigher is better · 204 reported | -7.9% | 0.9% | 35% | 50% | |
| Free cash flow yieldHigher is better · 126 reported | -6.5% | -14.4% | 66% | 20% | |
| Book yieldHigher is better · 185 reported | 10.4% | 64.7% | 13% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 127 | 302M USD | 8 | 42 | |
| 127 | 139M USD | 8 | 32 | |
| 127 | 223M USD | 8 | 34 | |
| 127 | 303M USD | 8 | 27 | |
| 127 | 172M USD | 8 | 34 | |
| 127 | 289M USD | 8 | ||
| 127 | 227M USD | 8 | 24 | |
| 127 | 113M USD | 8 | 23 | |
| 178 | 1.9B CNY (≈$270M) | 7 | 17 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score